We are live on ! Find out more
CBAY

Cymabay Therapeutics

Delisted

CBAY was delisted on the 21st of March, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Associates
26
T. Rowe Price Associates
Maryland
$9.22M -$160K -12,823 -2%
Northern Trust
27
Northern Trust
Illinois
$9.12M +$7.07M +565,327 +497%
RSCM
28
Rock Springs Capital Management
Maryland
$7.78M +$1.13M +90,000 +18%
UBS AM
29
UBS AM
Illinois
$7.63M -$312K -24,930 -4%
Geode Capital Management
30
Geode Capital Management
Massachusetts
$7.53M +$2.25M +180,004 +47%
OFM
31
Omega Fund Management
Massachusetts
$7.4M
CS
32
Candriam SCA
Luxembourg
$6.31M +$2.82M +225,000 +92%
LOAMU
33
Lombard Odier Asset Management (USA)
New York
$5.09M -$313K -25,000 -6%
OA
34
Omega Advisors
New York
$5.06M +$1.22M +97,200 +35%
Invesco
35
Invesco
Georgia
$4.73M +$1.38M +109,996 +45%
DCM
36
DAFNA Capital Management
California
$3.95M -$367K -29,332 -9%
A
37
Abingworth
United Kingdom
$3.67M
Bank of New York Mellon
38
Bank of New York Mellon
New York
$3.25M +$1.43M +114,001 +89%
TCIM
39
TIAA CREF Investment Management
New York
$2.84M +$2.65M +211,886 New
Allianz Asset Management
40
Allianz Asset Management
Germany
$2.56M +$798K +63,787 +50%
TCM
41
Tekla Capital Management
Massachusetts
$2.28M
SI
42
SCP Investment
California
$2.15M -$626K -50,000 -24%
Morgan Stanley
43
Morgan Stanley
New York
$2.03M +$1.33M +106,502 +239%
State of Wisconsin Investment Board
44
State of Wisconsin Investment Board
Wisconsin
$1.97M +$208K +16,600 +13%
IBT
45
International Biotechnology Trust
United Kingdom
$1.95M
UBS Group
46
UBS Group
Switzerland
$1.9M +$1.37M +109,349 +339%
Deutsche Bank
47
Deutsche Bank
Germany
$1.82M -$908K -72,535 -35%
Charles Schwab
48
Charles Schwab
California
$1.75M +$1.37M +109,800 +539%
TA
49
Teachers Advisors
New York
$1.51M +$1.41M +112,748 New
JGC
50
J. Goldman & Co
New York
$1.48M -$4.33M -345,666 -76%